Introduction: Preliminary evidence in adults with spinal muscular atrophy (SMA) and in
INTRODUCTION
Spinal muscular atrophy (SMA) is a progressive neuromuscular disorder characterized by decreased muscle strength and motor function due to degeneration of motor neurons in the spinal cord and brainstem. 1 The clinical spectrum in affected individuals varies widely from severe generalized weakness (SMA types I and II) to modest proximal muscle weakness (SMA types III and IV). [2] [3] [4] In spite of considerable heterogeneity, most patients with SMA have markedly reduced muscle strength. 5, 6 A representative study demonstrated that SMA subjects have only ~ 5% of predicted age/gender reference values for knee extensor strength and ~ 20% of predicted strength for knee, elbow, and finger flexors. 7 Most studies in patients with SMA types II and III with a 12-month or shorter observation period show overall stability in measures of strength. 8, 9 However, studies with longer follow-up periods clearly demonstrate progressive muscle weakness and motor disability. 3, 4, 7, [10] [11] [12] [13] A number of studies have reported an association between strength and motor function in SMA. 7, 9, [14] [15] [16] At least 70% of patients with SMA type II and 40% of patients with type III require assistance with self-care, and 90% with type II and 60% with type III require assistance with mobility. 10 A wealth of data supports that strength and function decrease over time, muscle strength is associated with motor function, and change in strength correlates with change in function in individuals with SMA types II and III.
Historically, patients with neuromuscular disorders (NMD), including SMA, have been advised to avoid strenuous physical activity to avoid possible further muscle damage and to preserve their remaining strength. [17] [18] [19] [20] However, over the past 2 decades, studies in both animal models and humans with motor neuron disease suggest that strength training is not only safe, but potentially beneficial. [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] Grondard et al.
trained neonatal mice expected to develop an SMA phenotype to run on a wheel for Resistance Strength Training & SMA progressively longer durations and at faster speeds. 34 Exercise-trained mice, compared to those without such training, had a mean increase in survival, improved motor function, reduced muscle atrophy, and a lower rate of neuronal apoptosis and neuronal death in the ventral horn of the spinal cord. This study provided the first compelling evidence for the potential benefit of exercise on lifespan, motor function, and severity in the SMA phenotype. Clinical studies in human subjects are limited. However, 3 clinical studies that include adults with SMA (along with adults with other types of NMD) have reported improved muscle strength and motor function after resistance training exercise programs. 23, 27, 28 Muscle strength increased from 2%-83% without excessive soreness or fatigue, suggesting that resistance exercise was well tolerated and could result in increased strength in some subjects with NMD.
SMA has substantial morbidity and mortality, a significant effect on quality of life,
and as yet, no proven disease-altering treatments. 35 Since individuals with SMA lose strength and function over time, younger patients with SMA have better strength and motor function than older ones. 3, 4, 7, 10, 11, 36 As a result, an earlier intervention is likely to be more effective than one later in the disease course. A progressive resistance training (PRT) exercise program has the potential to increase strength and improve motor function in children and young adults with SMA. PRT requires that muscles contract against an opposing force generated by some type of resistance (e.g., body weight, resistance bands, free weights) and involves a systematic increase in resistance training parameters to improve an individual's ability to exert force. Clinicians do not encourage patients with SMA to participate in PRT 46, 47 due to the lack of definitive literature disputing the long-standing concern of performing PRT in NMD. Therefore, further research is needed. The purpose of this pilot study was to examine the feasibility, safety, and effects of a PRT exercise program in a cohort of children and young adults with SMA. Our hypothesis was that children and adolescents with SMA types II and III could safely participate in and adhere to a 12-week, homebased, supervised PRT exercise program. Such preliminary data are a critical first step toward future studies to determine whether exercise programs such as PRT can help maintain or improve function in children with SMA.
MATERIALS AND METHODS

Participants
This was an observational study of a cohort of SMA patients recruited from an existing natural history database. Approval was provided by the Institutional Review
Board at the University of Utah. Study inclusion criteria were: (1) ages 5-21 years; (2) diagnosis of SMA type II or III; (3) some antigravity strength in elbow flexors (EF), and (4) place of residence within a 60-minute, or 60-mile, drive of the University of Utah.
(NCT01233817) Exclusion criteria were: (1) planned surgery or out-of-town trips during the proposed PRT intervention period; (2) inability to travel to study center for testing;
and (3) neurological diagnosis other than SMA. Written informed consent (for participants ≥18 years), parental consent (for participants <18 years) and assent (for participants ≥7 years) were obtained from all participants.
Measures
Feasibility. Feasibility was assessed by measuring: 1) the number of patients Motor assessments were performed at baseline, 6-weeks, and 12-weeks. The majority of the assessments were performed by 2 physical therapists working in a hospital-based clinic, both of whom administer the outcome measures regularly as part
Resistance Strength Training & SMA of an ongoing SMA natural history study and who administered the outcome measures as part of a previous clinical drug trial in SMA. 48 Strength assessment schedules varied depending on the measure collected. Quantitative muscle analysis (QMA) and HHD were administered twice at baseline; manual muscle testing (MMT) was administered only once at baseline. QMA was performed by a single physical therapist evaluator who was trained and supervised by an investigator (EG) with substantial experience using this technique in children with NMD. Two physical therapist evaluators who were trained and experienced in using HHD performed all HHD assessments. MMT was always carried out at the participants' homes by the physical therapists providing the homebased intervention. MMT definitions were reviewed with all therapists and included in their study binders.
Strength. Strength was assessed using 3 different measures: (1) QMA; (2) HHD;
and (3) MMT. Maximum voluntary isometric contraction (MVIC), measured using both QMA and HHD, has been used to assess muscle strength quantitatively in clinical trials of NMD, including SMA. 6, 14, [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] MMT is a clinical tool performed as part of the routine neurological exam and does not require extensive training. It is a practical outcome measure in multicenter neuromuscular disease trials and has also been used in studies of SMA. 5, 11, 12, 15, [59] [60] [61] . Upper extremity strength of shoulder flexors (SF), shoulder extensors (SE), elbow flexors (EF), and elbow extensors (EE) was assessed in all participants. Additionally, ambulatory participants underwent lower extremity strength assessments of the hip flexors (HF), hip extensors (HE), and knee extensors (KE).
Strength was assessed in all listed muscles with QMA 56 and MMT, 62 and in EF and KE with HHD, 49, 51 using previously described protocols. Inter-session reliability of QMA and HHD was assessed at baseline by measuring strength at 2 separate visits, 1 week apart to assure intra-rater reliability for the remainder of the study. 
Intervention
Design of the study PRT exercise program adhered to widely accepted PRT recommendations for children. 37, [39] [40] [41] [42] 68 In addition, the study followed the American in which target exertion was reached using weights to the last session were compared using paired t-tests. ICCs were used to examine test-retest reliability of QMA and HHD.
Data were analyzed using SAS 9.2 (SAS Inc., NC, USA). All P-values are from twosided comparisons.
RESULTS
Participants.
Sixteen children with SMA types II or III who lived locally were identified in the natural history database. Eleven children enrolled in the study. Two participants dropped out after completion of the baseline assessment and prior to start of PRT, one to undergo scoliosis surgery and the other due to lack of reliable transportation. Nine children (56% of those identified) completed the study.
Demographic characteristics are described in Table 1 .
Feasibility. All procedures were followed in accordance with the standards of the local institutional review board. Of 323 scheduled PRT sessions, 290 (90.4%) occurred per protocol, 24 (7.4%) did not occur, and 9 (2.2%) occurred but deviated from protocol.
Reasons for missed PRT sessions included: participant out of town, participant or family sick, no physical therapist available, car problems, participant too busy, family did not hear doorbell, and physical therapist family emergency, in descending order of frequency. Reasons for deviations from protocol included: physical therapist forgot warm-up, shorter visit due to family schedule, participant refusal, and only 1 set performed due to patient fatigue.
An average of 4 weeks was needed to identify a starting weight that resulted consistently in target exertion level for each exercise. The average time period during which participants were using weights and reaching target exertion consistently was 8.1 (0.3) weeks. During this period, participants were able to progress the exercise workload by increasing the weight lifted. (Table 2 Test-retest reliability of QMA and HHD. The test-retest reliability of QMA was high for all muscles (ICC=0.86 to 1.00 for 12 muscles) except for 2 lower extremity muscles (ICC=0.52 and 0.88) ( Table 3) . Test-retest reliability of HHD was high for
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DISCUSSION
Our purpose was to evaluate the safety and feasibility of a 12-week, home-based, supervised, 3 day/week PRT exercise program in children with SMA types II and III. All 9 participants who started the PRT exercise program completed it, with over 90% compliance to scheduled PRT sessions. This level of adherence is notable given the participants' time commitment as well as the large amount of coordination needed between participants, therapists, and study team members. Safety was a concern in performing a PRT program in children with SMA, since strengthening interventions have not been used in routine clinical practice and the effects of strengthening on children with significant weakness due to motor neuron disease was unknown. Therefore, we were pleased to find that PRT training was safe and well tolerated in this cohort.
Measures that supported exercise safety included: pain ratings (absent 99.5% of time), perceived exertion (unchanged throughout study), counts of adverse events (none noted), and the ability of participants to progress exercise load. There were no changes in HHD from pre-to post-PRT. While HHD was measured every 2 weeks by the physical therapist administering the PRT, there were several biases that likely influenced the usefulness of this data as a bi-weekly measure of safety. Biases included minimal training, lack of blinding, lack of reliability testing, technology malfunction, and variation in time, fatigue, and child effort. The perceptions of the parent, child, and therapist that strength did not decline could be validated with objective data in future studies.
Limitations discovered in this study could be addressed with additional HHD training, mechanisms to minimize technical issues with the equipment, or by using a reliable measure such as QMA. This was a prospective pilot study with a number of potential limitations, including a small number of participants from a single geographic location, clinical variability (participants included children with both SMA types II and III), a lack of reported reliability and unbiased evaluators for MMT, and no control group inherent in a pilot study. We had a limited number of participants, but the specificity of the program, the close follow up, home visits, and high rate of completion are all strengths of this study.
The increased attention and interaction with therapists on a weekly basis in this setting is also likely to have influenced performance. In addition, day-to-day and time-of-day variability in fatigue in this patient population may have affected energy and endurance at the time of PRT intervention. A larger group of subjects with SMA, follow-up over a period longer than 3 months, a control group, and further quantification of physiologic impact of exercise and exercise capacity in those with SMA are recommended to further validate our findings. In typically developing children, a greater number of training sessions per week are associated with higher strength gains after resistance training, and longer training interventions are more beneficial than similar programs of shorter duration. 37 It is currently unknown how affected motor neurons and muscles of children with SMA react to exercise of varying duration and intensity. These issues are of considerable interest for future studies of exercise in SMA.
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